Pharma news
Americas
Johnson & Johnson is set to buy biotech Massachusetts-based Momenta Pharmaceuticals for $6.5 billion, in a move aimed at strengthening its portfolio of autoimmune disease treatments. 20 August 2020
Americas
Mylan launched its generic version of Biogen’s $4 billion-a-year multiple sclerosis drug Tecfidera yesterday, August 19. 20 August 2020
Pharma
In a win for Novartis Pharmaceuticals, the US District Court for the district of Delaware has upheld the patent on its top-selling multiple sclerosis drug Gilenya. 18 August 2020
Pharma
The European Commission reached its first agreement to supply EU member states with an experimental COVID-19 vaccine with AstraZeneca late last week. 17 August 2020
Pharma
Big Pharma is looking for solutions to the COVID-19 pandemic wherever it can find them, so drug repurposing is more important than ever, as research lawyers Jakob Wested and John Liddicoat argue. 14 August 2020
Pharma
Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission. 14 August 2020
Pharma
Bayer has settled a patent infringement suit with generics manufacturer Apotex, after claiming that its version of a cancer treatment infringed two patents. 13 August 2020
Americas
US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine. 12 August 2020
Americas
McDermott Will & Emery has strengthened its IP practice in Boston with the addition of Michael Siekman and Jenny Chen as partners. 12 August 2020
Pharma
US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7. 10 August 2020